Moderna is ‘show-me story’ heading into Q3 earnings
Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...
Moderna CEO Bancel steps down as sales chief, Bloomberg News reports
Vaccine maker Moderna's chief executive officer Stephane Bancel will vacate his role as the company's chief commercial ...
Moderna’s Bancel steps down as sales chief, keeps CEO role
Moderna is trying to find a path to profitability in the wake of disappointing vaccine sales. In September, the company said ...
Business Insider2d
Moderna price target lowered to $59 from $70 at JPMorgan
JPMorgan analyst Jessica Fye lowered the firm’s price target on Moderna (MRNA) to $59 from $70 and keeps an Underweight rating on the shares. The firm updated estimates following Pfizer’s Comirnaty ...
Do the Covid vaccines provide long-lasting protection?
The Centers for Disease Control and Prevention now recommends that people ages 65 and up and those with weakened immune ...
JD Vance Tells Joe Rogan a Senator Has 'Serious' COVID Vaccine Side Effects
The revelation aired during Vance's interview on Joe Rogan's podcast episode with the potential next vice president.